Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

AstraZeneca synthesizes amide derivatives as cytokine production inhibitors

March 22, 2000

Lilly discloses new indole sPLA2 inhibitors

March 21, 2000

More good news about Enbrel: NEJM article describes efficacy in juvenile RA

March 20, 2000

Amides synthesized at AstraZeneca useful for cytokine-mediated diseases

March 17, 2000

Collgard receives orphan drug status for scleroderma therapy

March 15, 2000

New inhibitors of NOS, particularly iNOS, in early development at AstraZeneca

March 14, 2000

CE Mark granted for the Prosorba Column as rheumatoid arthritis Rx

March 14, 2000

Suntory's new antiinflammatory agents act as inhibitors of NF-kB

March 13, 2000

Taisho presents new series of cytokine production inhibitors

March 10, 2000

New nondrug treatment approved for rheumatoid arthritis in Canada

March 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...